Retina

Why the Spaeth Richman Contrast Sensitivity test is set to raise the standard of CS assessments

Realizing the potential of precision glaucoma therapy means understanding the foundational pillars of personalized medicine

Iveric Bio’s Erin Henry talks about the potential for the recently-FDA approved Izervay to address unmet needs in geographic atrophy patients

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Socioeconomic factors linked with NDI in infants screened for ROP

We look back on The Ophthalmologist's 2023 magazine covers

The Power List celebrates the world’s most inspiring and influential ophthalmologists

Pixium Vision’s CEO discusses bringing their PRIMA Bionic Vision System

Through Retro mode, NIDEK presents the future of retinal imaging in their unique, non-invasive retinal pseudo-3D pathology visualization modality